Tissue Diagnostic Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

TISSUE DIAGNOSTIC MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2017–2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Pharmacovigilance Market Overview
Tissue diagnosis is important tool in diagnosis, monitoring, and management of different types
of cancer conditions. Recognition of sign and symptoms of disease are done through biopsy, a
process of taking sample from region of interest such as skin, tissue or tumor for further
diagnosis. Biopsy are primarily done to look for cancer detection or to detect rejection of
transplanted organ draft.
Request Sample: https://www.coherentmarketinsights.com/insight/request-sample/1112
Biopsy is done to identify likely cause of cancerous and non-cancerous tissue, which are unable
to detect through CT-scan or X-rays. Depending on area of sample collection various biopsy
procedures are done such as endoscopic biopsy, bone marrow biopsy, skin biopsy, kidney biopsy,
liver biopsy, and prostate biopsy. Furthermore biopsy can be done using needle biopsy, CT
guided biopsy, Ultrasound biopsy, and surgical biopsy for the tissue diagnostic. According to the
American journal of Nephrology, 2015, Australia has the highest numbers of annual renal biopsy
rates (215 persons/million person/year) followed by the Finland (176 persons/million
person/year) and U.S. (175 persons/million person/year). The increased numbers of biopsy
procedure likely to fuel the growth of tissue diagnostic market, in near future.
Rising prevalence of different cancer incidences is major driving factor boosting the tissue
diagnostic market. According to American cancer Society (ACS), 1.6 million new cases of cancer
diagnosed in the U.S., in 2016. In addition, increase research funding in cancer treatment and
growing healthcare expenditure likely to show gradual rise in tissue diagnostic market.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
National Cancer Institute, in 2015, spends US$ 4,480 million on various types of cancer
research which includes breast cancer, colorectal cancer, cervical cancer, liver cancer, lung
cancer, leukemia, ovarian cancer and uterine cancer.
Rise in the prevalence of cancer incidences to boost the tissue diagnostic market
According to the United States Cancer statistics report published in 2014 by Centers of
Disease Control and Prevention (CDC), between 1999 and 2014, more than 1600 people a
day, died due to the cause of cancer. Although screening tests helps to detect cancer
condition at early stage, data from Healthy People 2020, an initiative form Department of
Health and Human Services, reveals that screening rate is still below the national targets set.
Combined data collected from CDC and National cancer institute (NCI) focus on the top 3
cancer incidences in male and female. In male prostate cancer incidence are higher, while in
females breast cancer are most dominated, followed by lung and colon cancer respectively
in both male and female.
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/1112
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
New and advanced methods of tissue diagnosis favors the market growth
Innovation in tissue diagnostic process for the efficient diagnostic testing such as Fluorescence
in situ hybridization (FISH), Immunohistochemistry (IHC) and In situ hybridization (ISH) raises the
opportunity to grow tissue diagnostic market in future. In September 2017, researchers at the
University of Texas, developed a new way of diagnosis by creating pen named as “MasSpec Pen”,
which is handheld devices able to distinguish healthy tissue and tumor tissue in just 10 seconds,
more than 150 times quicker than existing technology. These new tool provides improvement in
cancer treatment and minimizes the chances of recurrence by offering precise diagnostic
information, which eventually favors the growth in tissue diagnostic market.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/1112
Key players operated in the tissue diagnostic market are Biocare Medical, Agilent
technologies, Thermo Fisher Scientific, Sigma-Aldrich, Roche Diagnostics, Danaher corp.,
Biogenex Laboratories, Life Technologies and Abbott laboratories.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

Tissue diagnosis is important tool in diagnosis, monitoring, and management of different types of cancer conditions. Recognition of sign and symptoms of disease are done through biopsy, a process of taking sample from region of interest such as skin, tissue or tumor for further diagnosis. Biopsy are primarily done to look for cancer detection or to detect rejection of transplanted organ draft.